将AI诊断工具集成到阿尔茨海默病的临床实践中:障碍和解决方案
Muhammad Umer Suleman1, Muhammad Mursaleen1, Umer Khalil1
1Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan.
Annals of medicine and surgery (2012)
|February 12, 2026
概括
人工智能 (AI) 工具对早期阿尔茨海默氏症有希望.
科学领域:
- 神经科学和人工智能 人工智能
- 医学诊断和机器学习
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有重大的全球影响.
- 早期诊断阿尔茨海默病仍然是一个临床挑战,阻碍了及时干预.
- 人工智能 (AI) 为改善早期发现阿尔茨海默病提供了潜在的解决方案.
研究的目的:
- 审查和评估用于阿尔茨海默病检测的AI诊断工具的当前状态.
- 确定阻碍人工智能在阿尔茨海默病诊断中的临床应用的挑战.
- 提出应对这些挑战的策略,并促进人工智能融入临床实践.
主要方法:
- 对分析大脑成像,遗传数据和认知评估的AI系统进行叙事审查.
- 使用语音模式和可穿戴设备数据评估新兴的人工智能方法.
- 识别和分析临床实施障碍的障碍.
主要成果:
- 人工智能工具在各种数据模式中展示了用于阿尔茨海默病检测的潜力.
- 六个主要挑战阻碍了临床采用:数据限制,缺乏透明度,工作流程中断,监管不确定性,高成本和潜在的健康差异.
- 提出的解决方案包括协作数据库,透明的AI模型,临床医生教育,明确的法规和可扩展的基础设施.
结论:
- 人工智能诊断工具可以显著提高早期阿尔茨海默病的诊断和患者的结果.
- 解决技术,人力和系统挑战对于成功的AI集成至关重要.
- 需要协调努力,在各种医疗机构有效实施人工智能.
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:30Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35